ExL Pharma's Clinical Cost Containment conference provides concrete information and strategies for reducing expenses while still achieving sound, high quality and meaningful clinical trials. Case studies and best practices allow conference participants to learn what other leading and successful companies are doing to minimize costs. For more information on this event Click Here.

This event addresses strategies for developing, implementing and benefiting from the convergence of drug development and healthcare IT. Featured presenters include Dr. C. Martin Harris, CIO of the Cleveland Clinic, Michael Ibara, Head of Pharmacovigilance Information Management at Pfizer and Somesh Nigam, Director of Innovation Implementation at Johnson & Johnson. To learn more about this unique event that attracts visionaries from both the pharma and healthcare industries please click here.

Discover the Latest Trial Development and Regulatory Strategies and Determine Appropriate Biomarkers and Endpoints for Optimum Trial Results.

Building on the inaugural 2007 conference, CBI’s 2nd Annual Oncology Clinical Trial Summit focuses on the complexity of oncology clinical trials which require a different approach than trials in other therapeutic areas. Determining appropriate trial designs, effectively recruiting and enrolling patients, determining biomarkers and choosing the most effective endpoints all contribute to the complexity of managing oncology trials. The regulatory landscape in oncology is changing and it is critical to understand the impact that these changes will have on cancer trials.

Hear Expert Analysis and Insight on:

• The current metrics for the time, cost and success rates for cancer therapeutics compared to other therapeutic areas
• Strategies establishing viable relationships with the Oncology Review Divisions to facilitate product development
• Tools to determine the utility and feasibility of biomarkers in preclinical models
• NCI efforts to create resources to address imaging standards for drug response
• Ways to ensure the integrity of the Progression Free Survival endpoint

Phone: (215) 442-6100

Fax: (215) 442-6199

http://www.diahome.org

Phone: (215) 442-6100

Fax: (215) 442-6199

http://www.diahome.org

The 4th Annual Clinical Performance Metrics & Benchmarking Summit will once again feature senior level executives and clinical project teams from pharmaceutical and biotechnology companies sharing different applications of clinical performance metrics and process improvements. This year’s program features case studies from Centocor, Bristol-Myers Squibb, Wyeth, Merck, AstraZeneca and Sanofi-Aventis on developing leaner and more efficient clinical processes.

Phone: (215) 442-6100

Fax: (215) 442-6199

http://www.diahome.org

ExL Pharma's 4th MSL Best Practices Conference will address methods to maximize the impact of Medical Science Liaisons, who act as ambassadors to Key Opinion Leaders outside their companies, and also as key players in collecting and disseminating competitive intelligence and clinical data within their companies. Attendees will hear best practices that have been successfully implemented by our experienced speaking faculty that can be applied in their own positions as MSLs or MSL managers.

New changes to the ACCME guidelines will be outlined, with special attention paid to changes on the horizon in light of the opinion published by the AMA regarding the pharmaceutical industry’s role in Continuing Medical Education. MSLs will learn effective methods of communicating with KOLs and tips from sales and marketing teams on getting through the door and capturing the attention of these doctors to whom access has become more and more restricted. Sessions will be offered to focus on the specific challenges of managing these educated professionals, teaching how to recruit and retain the best possible MSL force.

In response to feedback received in past meetings, this year we will offer a tracked agenda, ensuring that the needs and interests of both MSLs and their managers will be addressed directly, and that each session will offer information that our attendees can apply in their work. New topics have been introduced this year, including an in depth look at the regulations governing MSL activities that will be offered by a leader in the legal community and a personal case study on the career of an MSL, moving from academia to Medical Science Liaison to Chief Medical Officer!

Please contact Sarah Ide, Conference producer, at info@exlpharma.net for more info.